Hematachek

FDA 510(k) K964452 · Richmond Diagnostics, Inc.

Substantially Equivalent

510(k) numberK964452

Submission

Device name
Hematachek
Applicant
Richmond Diagnostics, Inc.
New Brunswick, NJ, US
Received
November 6, 1996
Decision date
February 20, 1997
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
GLK – Control, Hematocrit
Device class
Class II (moderate risk)
Regulation
21 CFR 864.8625
Specialty
Hematology

Other 510(k)s with product code GLK

510(k)DeviceApplicantDecision
K121467Eurotrol Hematocrit ControlGLK · Traditional Eurotrol B.V.05/10/2013SE
K021924Medica Easyqc Hematocrit ControlGLK · Traditional Bionostics, Inc.06/24/2002SE
K020618Aalto Scientific Mirco Hematocrit ControlGLK · Traditional Aalto Scientific, Ltd.05/14/2002SE
K961807Certain HCT Level a & Level B/Cvm HCT Levels 1,2,3, & 4GLK · Traditional Ciba Corning Diagnostics Corp.07/26/1996SE
K924926Msi-HctGLK · Traditional Medical Specialties, Inc.01/07/1993SE
K893562A.Qc HCT Level 1 and 2GLK · Traditional Johnson & Johnson Professionals, Inc.07/14/1989SE

Questions and answers

When was Hematachek cleared by the FDA?

Hematachek (K964452) received a 510(k) decision of Substantially Equivalent on February 20, 1997, 106 days after the submission was received.

What is the product code of K964452?

The FDA product code is GLK – Control, Hematocrit, a Class II (moderate risk) device regulated under 21 CFR 864.8625.